These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Nicotine-replacement products in smoking cessation: a review. Alsagoff F; Lee HP Singapore Med J; 1993 Dec; 34(6):505-10. PubMed ID: 8153711 [TBL] [Abstract][Full Text] [Related]
26. Transdermal nicotine substitution: pharmacokinetics of nicotine and cotinine. Keller-Stanislawski B; Caspary S; Merz PG; Bonn R; Wolff M; Rietbrock N Int J Clin Pharmacol Ther Toxicol; 1993 Sep; 31(9):417-21. PubMed ID: 8225689 [TBL] [Abstract][Full Text] [Related]
27. Nicotine poisoning due to intravenous injection of cigarette soakage. Hagiya K; Mizutani T; Yasuda S; Kawano S Hum Exp Toxicol; 2010 May; 29(5):427-9. PubMed ID: 20068013 [TBL] [Abstract][Full Text] [Related]
28. [Smoking cessation with the nicotine patch]. Batra A; Buchkremer G Z Arztl Fortbild (Jena); 1995 Oct; 89(5):505-9. PubMed ID: 8578778 [TBL] [Abstract][Full Text] [Related]
29. The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day. Daughton DM; Fortmann SP; Glover ED; Hatsukami DK; Heatley SA; Lichtenstein E; Repsher L; Millatmal T; Killen JD; Nowak RT; Ullrich F; Patil KD; Rennard SI Prev Med; 1999 Feb; 28(2):113-8. PubMed ID: 10048102 [TBL] [Abstract][Full Text] [Related]
30. Skin tolerability of transdermal patches. Wohlrab J; Kreft B; Tamke B Expert Opin Drug Deliv; 2011 Jul; 8(7):939-48. PubMed ID: 21506903 [TBL] [Abstract][Full Text] [Related]
31. Transdermal nicotine patch for postoperative pain management: a pilot dose-ranging study. Hong D; Conell-Price J; Cheng S; Flood P Anesth Analg; 2008 Sep; 107(3):1005-10. PubMed ID: 18713921 [TBL] [Abstract][Full Text] [Related]
32. Changes in compulsion and anxiety symptoms with nicotine transdermal patches in non-smoking obsessive-compulsive disorder patients. Salín-Pascual RJ; Basañez-Villa E Rev Invest Clin; 2003; 55(6):650-4. PubMed ID: 15011734 [TBL] [Abstract][Full Text] [Related]
33. Transdermal nicotine suppresses cutaneous inflammation. Mills CM; Hill SA; Marks R Arch Dermatol; 1997 Jul; 133(7):823-5. PubMed ID: 9236519 [TBL] [Abstract][Full Text] [Related]
40. The safety, tolerability and efficacy of transdermal nicotine (Nicotinell TTS) in initially hospitalised patients. Martin PD; Robinson GM N Z Med J; 1995 Jan; 108(992):6-8. PubMed ID: 7862363 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]